In recent years, there has been alarming growth in methamphetamine (meth) and cocaine use and their involvement in overdose fatalities. In 2004, they were the most common illicit drugs used by state and federal prison inmates and convicted jail inmates. However, usage steadily declined among arrestees for more than a decade and was overtaken by opioids. The “meth problem” never really disappeared, and it began to accelerate around 2013, a trend that is expected to continue. There have also been steep increases in cocaine overdose deaths, mainly driven by its use in combination with opioids (75% of the time), whereas half of meth deaths involve opioids, but fatalities attributed to methamphetamine alone are also on the rise. Currently, there are no FDA-approved medications for treatment, nor antidotes that can prevent stimulant overdose fatality.
RSAT programs, especially in eastern states, may be faced with growing meth use among clients with opioid use disorder (OUD), including those receiving MAT, as well as growing numbers of chronic meth users. However, successfully treating individuals in RSAT programs who use meth and other stimulants is not only possible, it also can be achieved without separate dedicated programs or drastic departures from evidence-based behavioral interventions already in place.
This webinar will introduce the new RSAT manual designed to help staff integrate specific approaches that have been successful with clients involved with meth and other stimulants – building upon the experience of many correctional systems west of the Mississippi.
Please check the box next to the following questions if the answer is 'yes'.
Please enter the applicable Event Date if there is an Event associated with this TTA.
When entering an Event Date, the Time is also required.
If the TTA is targeted to a particular audience or location, please complete the questions below.
Milestones are an element, activity, work product, or key task associated with completing the TTA (e.g. kick-off meeting, collect data from stake holders, deliver initial data analysis).
Please complete the fields below, if applicable, to create a milestone for this TTA.
Please respond to the Performance Metrics below. The Performance Metrics questions are based on the TTA Type indicated in the General Information section of the TTA.
Please submit a signed letter of support from your agency’s executive or other senior staff member. The letter can be emailed to or uploaded with this request. The letter should be submitted on official letterhead and include the following information:
- General information regarding the request for TTA services, i.e., the who, what, where, when, and why.
- The organizational and/or community needs specific to the request for TTA services.
- The benefits or anticipated outcomes from the receipt of TTA services.
By submitting this application to BJA NTTAC, I understand that upon approval of this application for TTA, the requestor agrees to keep BJA NTTAC informed of any circumstances that may impact the delivery of the TTA, including changes in the date of the event, event cancellation, or difficulties communicating with the assigned TTA provider.
Please call [site:phone] if you need further assistance completing this application.